June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Pharmacodynamic study of Intravitreal liposomal doxorubicin by matrix-assisted laser desorption/ionization-mass spectrometry (MALDI/MS)
Author Affiliations & Notes
  • Hsi-Kung Kuo
    Ophthalmology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan
  • Yi-Hao Chen
    Ophthalmology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan
  • Pei-Chang Wu
    Ophthalmology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan
  • Footnotes
    Commercial Relationships Hsi-Kung Kuo, None; Yi-Hao Chen, None; Pei-Chang Wu, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 5055. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Hsi-Kung Kuo, Yi-Hao Chen, Pei-Chang Wu; Pharmacodynamic study of Intravitreal liposomal doxorubicin by matrix-assisted laser desorption/ionization-mass spectrometry (MALDI/MS). Invest. Ophthalmol. Vis. Sci. 2013;54(15):5055.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: to investigate the pharmacodynamics of doxorubicin and liposomal doxorubicin (Lipo-Dox) after intravitreal injection.

Methods: Pigmented rabbits were used. One eye accepted intravitreal injection of doxorubicin or Lipo-Dox (10 μg/ml). Another eye was injected with 0.1 ml BSS as the control. To evaluate the pharmacodynamic change of the drugs, the animals were sacrificed on the day 1, 3, 5, 7 and 14 after the injection. The vitreous contents and retina extracts were prepared for LC/MS/MS and MALDI/MS study. On the matrix-assisted laser desorption/ionization-imaging mass spectrometry (MALDI/IMS) group, the full eye sections are prepared from cryo-section.

Results: Pharmacodynamic study by MALDI/MS showed liposomal doxorubicin existed in the vitreous for at least 14 days with the highest density on day 7. The result is compatible with the slowly released property of liposomal drugs. To study the drug distribution with MALDI/IMS was failed due to background interference.

Conclusions: Intravitreal injection of liposomal doxorubicin can obtain a sustained drug concentration for at least 14 days with the peak on day7.

Keywords: 655 proliferative vitreoretinopathy • 503 drug toxicity/drug effects  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×